Table 1.
Characteristics of the study population: 200 MI survivors in Augsburg, Germany, 14 May 2003–24 February 2004.
Table 1. Characteristics of the study population: 200 MI survivors in Augsburg, Germany, 14 May 2003–24 February 2004. | |
Characteristic | Mean ± SD or total n (%) |
Age (years) | 61.9 ± 9.0 |
Last MI to study (years) | 2.1 ± 0.9 |
BMI (kg/m²) | 28.8 ± 4.0 |
Alcohol intake per day (g) | 18.5 ± 22.6 |
Systolic blood pressure (mmHg) | 128.4 ± 19.9 |
Total cholesterol (mg/dL) | 181.0 ± 38.8 |
HDL (mg/dL) | 47.9 ± 11.8 |
HbA1c (%) | 5.6 ± 0.7 |
CRP (mg/L) | 2.2 ± 4.5 |
Lp-PLA2 (ng/mL) | 188.6 ± 51.1 |
Sex (male) | 164 (82) |
Smoking | |
Ex-smokers | 126 (63) |
Occasional smokers | 9 (4.5) |
Never smokers | 65 (32.5) |
No. of MIs | |
1 | 175 (88) |
> 1 | 25 (12) |
BMI (kg/m²) | |
≤ 25 | 31 (16) |
> 25 | 168 (84) |
HbA1c (%) | |
< 6.5 | 181 (90) |
≥ 6.5 | 19 (10) |
Medical history | |
Angina pectoris | 42 (21) |
Arrhythmias | 48 (24) |
Congestive heart failure | 26 (13) |
Stroke | 13 (7) |
Diabetes mellitus | 35 (18) |
Hypertension | 102 (51) |
Chronic bronchitis | 16 (8) |
Asthma | 9 (5) |
Emphysema | 2 (1) |
Hay fever | 20 (10) |
Chronic renal disease | 10 (5) |
Osteoarthritis | 35 (18) |
Medications | |
Beta blockers | 183 (92) |
ACE inhibitors | 139 (70) |
Diuretics | 79 (40) |
Statins | 173 (87) |
Fibrates | 2 (1) |
ACE, angiotensin converting enzyme. |